Aesthetics

How does an aesthetic practice decide whether to invest in body toning technologies? We asked several aesthetic physicians to share what they’ve learned about what differentiates the technologies and more.

In this weekly report, we curate a list of consumer media articles on aesthetic topics to keep you up-to-date with what your patients are reading. Here is the Feb. 24 edition:

“Explain [to patients] that even though the energy device may not deliver this huge ‘wow’ factor immediately, it will likely enhance results from injectables without creating the unnatural look of high-dose injectables.” Dr. Jegasothy, M.D., Miami Skin Institute.

Dr. Jegasothy explains how she tackles the decision of which combination therapy will result in the best possible outcome for her patients. According to her, it depends on multiple factors.

The subtle results of long-wavelength devices combined with the more dramatic results of injectables can last for years and deliver more natural results than those of injectables alone.

Dr. Capi Wever discusses the prevalence of BDD in aesthetics, how to identify the psychological disorder and what to do if you discover you’ve treated a patient with BDD.

AACS will be hosting its inaugural “Women in Cosmetic Surgery Breakfast” at this year’s scientific meeting, with nine women panelists discussing the unique challenges they’ve faced and offering advice for women beginning careers in the aesthetic space.

Understanding differences among preparations and dilutions of botulinum toxin type A can improve clinical practice, according to industry experts.

In this weekly report, we curate a list of consumer media articles on aesthetic topics to keep you up-to-date with what your patients are reading. Here is the Feb. 17 edition:

Collective results from the SAKURA phase 3 clinical trial program investigating daxibotulinumtoxinA for injection for the treatment of moderate-to-severe glabellar lines show that the neuromodulator provides generally safe and long-lasting results.

Anti-aging treatments should begin sooner than later in menopausal patients, but do you know how to identify premature and early menopause? (Your patients don’t.)

According to Dr. Joe Niamtu III, knowing when to treat, when not to treat, and when to refer are all virtues of prudent injectors, regardless of specialty, seniority or type of practice.

It’s known that combination therapies can be used to create ideal treatment outcomes, but according to Dr. Suneel Chilukuri, results may also last longer than originally thought.

In this weekly report, we curate a list of consumer media articles on aesthetic topics to keep you up-to-date with what your patients are reading.

“The Aesthetic Authority has arrived. It is quite simply the first 'true' multi-specialty aesthetic publication that is created by and designed for today's aesthetic practitioners. The goal is to provide useful information and tips and pearls that will help all of us in our practices.” ⏤Dr. Randolph Waldman.

An analysis by Vanguard Communications suggests more weight is attached to physician patient reviews compared to those of hotels and restaurants.

Revance Therapeutics announces BLA acceptance for their long-acting neuromodulator, DaxibotulinumtoxinA (DAXI), with an action date set for November 25, 2020.

As nonsurgical aesthetic procedures continue to grow, so do the number of medical spas that perform cosmetic treatments. According to Dr. Renato Saltz, that’s not necessarily a bad thing.

Dr. Mark Beaty sat down with the Aesthetic Authority at the 2019 Global Aesthetics Conference to talk about two radiofrequency treatments that, he says, stand out for skin tightening.

New device? Dr. Suneel Chilukuri discusses how to create a smooth and prosperous transition into your practice.

Millennials think of aesthetic treatments no differently than other beauty appointments, according to Dr. Ava Shamban. These are their top facial concerns.